BeStock  
Stocks › Biotechnology › AUPH

Aurinia Pharmaceuticals AUPH

US equityMarket cap rank #2690Biotechnology
$14.70 −$0.19 (-1.28%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $14.64 -0.41%
Open$14.69
Prev close$14.89
Day range$14.63 – $14.97
Volume1.34M
Market cap$1.97B
P/E (TTM)6.4
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$83.70M+13.9% YoY
Operating profit$35.36M+18.9% YoY
Net profit$31.70M+0.5% YoY
Diluted EPS$0.23+0.0% YoY
Free cash flow$46.34M+4.4% YoY
Operating cash flow$46.37M

Revenue, last 8 quarters

$59.9MDec '24$62.5MMar '25$70.0MJun '25$73.5MSep '25$77.1MDec '25$77.7MMar '26$83.2MJun '26$83.7MSep '26

Net profit, last 8 quarters

$1.4MDec '24$23.3MMar '25$21.5MJun '25$31.6MSep '25$210.8MDec '25$34.4MMar '26$37.4MJun '26$31.7MSep '26

Diluted EPS by quarter

0.01Dec '240.16Mar '250.16Jun '250.23Sep '251.53Dec '250.25Mar '260.28Jun '260.23Sep '26

Free cash flow by quarter

$30.1MDec '24$1.3MMar '25$44.1MJun '25$44.4MSep '25$45.6MDec '25$32.5MMar '26$52.6MJun '26$46.3MSep '26

Annual revenue

$50.1MFY20$45.6MFY21$134.0MFY22$175.5MFY23$235.1MFY24$283.1MFY25

Profitability & balance sheet

Gross margin90.6%
Operating margin48.6%
Net margin97.7%
Return on equity61.4%
Return on assets46.4%
Return on invested capital53.1%
Current ratio6.12
Liabilities / assets20.4%
Cash & investments$486.88M
Total debt$40.71M
Net cash (debt)$446.18M
Free cash flow / sales55.0%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $83.70M $83.22M $77.71M $283.06M $77.11M
Total Operating Revenue $83.70M $83.22M $77.71M $283.06M $77.11M
Cost of Revenue $8.31M $6.56M $6.51M $32.67M $8.80M
Gross Profit $75.39M $76.67M $71.20M $250.39M $68.32M
Operating Expense $40.03M $30.32M $29.78M $143.83M $35.08M
Selling and Admin Expenses $24.68M $23.51M $22.03M $101.79M $29.26M
-Selling & Marketing Expense $787,000.00 $535,000.00 $327,000.00 $3.21M $785,000.00
-General & Admin Expense $23.90M $22.97M $21.70M $98.59M $28.47M
Research & Development $16.61M $13.05M $7.47M $32.51M $10.90M
Other Operating Expenses -$1.27M -$6.23M $279,000.00 $9.53M -$5.07M
Operating Profit $35.36M $46.34M $41.42M $106.56M $33.24M
Net Non-Operating Interest Income (Expense) $3.35M $2.45M $2.50M $9.24M $2.45M
Non-Operating Interest Income $4.22M $3.39M $3.52M $13.57M $3.50M
Non-Operating Interest Expense $867,000.00 $948,000.00 $1.01M $4.33M $1.05M
Special Income (Charges) $0.00 $0.00 $0.00 -$1.65M $0.00
-Less:Restructuring and Mergern & Acquisition $0.00 $0.00 $0.00 $1.65M $0.00
Pretax Profit $38.72M $48.79M $43.93M $114.16M $35.69M
Tax $7.01M $11.37M $9.57M -$173.05M -$175.10M
Net Profit $31.70M $37.41M $34.36M $287.20M $210.79M
Profit from Continuing Operations $31.70M $37.41M $34.36M $287.20M $210.79M
Net Income to Parent Company $31.70M $37.41M $34.36M $287.20M $210.79M
Net Income to Common Stockholders $31.70M $37.41M $34.36M $287.20M $210.79M
Basic EPS $0.24 $0.29 $0.26 $2.14 $1.60
Diluted EPS $0.23 $0.28 $0.25 $2.07 $1.53
Other Income (Expense) – – – -$1.65M $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $825.70M $792.26M $724.00M $751.59M $751.59M
Total Current Assets $587.89M $541.32M $480.24M $491.97M $491.97M
Cash and Cash Equivalents & Short-Term Investments $486.88M $443.12M $378.78M $398.00M $398.00M
-Cash and Cash Equivalents $46.15M $179.83M $41.01M $80.21M $80.21M
-Short Term Investments $440.74M $263.29M $337.78M $317.78M $317.78M
Receivables $47.41M $41.14M $49.18M $41.45M $41.45M
-Accounts Receivable $47.41M $41.14M $49.18M $41.45M $41.45M
Prepaid Assets $5.92M $10.53M $4.12M $5.75M $5.75M
Inventory $43.73M $45.15M $46.41M $45.69M $45.69M
Other Current Assets $3.95M $1.38M $1.76M $1.08M $1.08M
Total Non-Current Assets $237.82M $250.94M $243.75M $259.62M $259.62M
Net PPE $63.90M $68.53M $73.15M $79.57M $79.57M
-Gross PPE $67.43M $71.93M $76.43M $82.73M $82.73M
-Accumulated Depreciation -$3.53M -$3.40M -$3.28M -$3.15M -$3.15M
Goodwill and Other Intangible Assets $3.17M $3.38M $3.59M $3.76M $3.76M
-Other Intangible Assets $3.17M $3.38M $3.59M $3.76M $3.76M
Non-Current Deferred Assets $170.65M $178.94M $166.92M $176.19M $176.19M
Other Non-Current Assets $93,000.00 $93,000.00 $93,000.00 $93,000.00 $93,000.00
Total Liabilities $168.19M $177.40M $156.37M $170.26M $170.26M
Total Current Liabilities $96.01M $99.89M $86.56M $93.72M $93.72M
Payables $4.05M $2.60M $4.20M $5.32M $5.32M
-Accounts Payable $3.01M $1.74M $2.66M $3.31M $3.31M
-Total Tax Payable $1.03M $860,000.00 $1.54M $2.01M $2.01M
Current Accrued Expenses $62.27M $63.25M $56.65M $64.61M $64.61M
Short-Term Debt and Capital Lease Obligation $17.96M $18.18M $18.14M $17.59M $17.59M
-Current Capital Lease Obligation $17.96M $18.18M $18.14M $17.59M $17.59M
Current Deferred Liabilities $10.41M $10.59M $5.04M $3.72M $3.72M
Other Current Liabilities $1.32M $5.27M $2.52M $2.48M $2.48M
Total Non-Current Liabilities $72.18M $77.51M $69.82M $76.53M $76.53M
Long Term Debt and Capital Lease Obligation $40.71M $45.95M $50.50M $57.22M $57.22M
-Long Term Capital Lease Obligation $40.71M $45.95M $50.50M $57.22M $57.22M
Non-Current Deferred Liabilities $30.29M $30.61M $12.41M $12.65M $12.65M
Other Non-Current Liabilities $1.19M $945,000.00 $6.90M $6.66M $6.66M
Total Equity $657.52M $614.86M $567.63M $581.33M $581.33M
Stockholders' Equity $657.52M $614.86M $567.63M $581.33M $581.33M
Capital Stock $1.13B $1.12B $1.09B $1.12B $1.12B
-Common Stock $1.13B $1.12B $1.09B $1.12B $1.12B
Additional Paid-In Capital $77.04M $76.19M $96.87M $111.26M $111.26M
Retained Earnings -$545.90M -$577.60M -$615.01M -$649.37M -$649.37M
Gains/Losses Not Affecting Retained Earnings -$1.13M -$977,000.00 -$880,000.00 -$599,000.00 -$599,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $46.37M $52.57M $32.56M $135.66M $45.67M
Net cash flow from continuing operations $46.37M $52.57M $32.56M $135.66M $45.67M
Net Income from Continuing Operations $31.70M $37.41M $34.36M $287.20M $210.79M
Gain/Loss from Continuing Operations -$1.63M -$561,000.00 -$416,000.00 $9.69M $367,000.00
Depreciation & Depletion & Amortization $4.84M $4.83M $4.82M $19.45M $4.86M
Deferred Tax $8.28M $11.11M $9.28M -$176.19M -$176.19M
Other Non-Cash Items $584,000.00 -$2.66M $581,000.00 -$200,000.00 -$5.05M
Change in Working Capital -$1.60M $1.47M -$12.87M -$8.78M $6.50M
-Change in Receivables -$6.28M $8.04M -$7.72M -$4.91M -$10.73M
-Change in Inventory $1.42M $1.26M -$720,000.00 -$6.46M -$897,000.00
-Change in Prepaid Assets $2.05M -$5.98M $950,000.00 $5.52M $4.58M
-Change in Payables and Accrued Expense $1.94M -$2.24M -$6.24M -$6.53M $14.22M
-Change in Other Current Assets $0.00 – – $730,000.00 $0.00
-Change in Other Current Liabilities -$229,000.00 -$227,000.00 -$214,000.00 -$802,000.00 -$202,000.00
-Change In Other Working Capital -$503,000.00 $624,000.00 $1.08M $3.67M -$482,000.00
Net cash flow from investing -$175.73M $81.45M -$18.08M -$32.77M -$36.76M
Net Cash Flow from Continuing Investing Activities -$175.73M $81.45M -$18.08M -$32.77M -$36.76M
Net PPE Purchase and Sale -$24,000.00 $0.00 -$39,000.00 -$252,000.00 -$72,000.00
Net Business Purchase and Sale $0.00 – – – –
Net Investment Purchase and Sale -$175.71M $76.24M -$18.04M -$32.52M -$36.68M
Financing Cash Flow -$4.32M $4.81M -$53.69M -$106.11M -$1.89M
Net Cash Flow from Continuing Financing Activities -$4.32M $4.81M -$53.69M -$106.11M -$1.89M
Net Issuance Payments Of Debt -$3.84M -$3.41M -$3.65M -$13.14M -$3.49M
Net Common Stock Issuance $0.00 -$38.72M -$36.17M -$98.16M $0.00
Proceeds from Stock Option Exercised $10.41M $58.80M $713,000.00 $14.95M $1.96M
Net Other Financing Charges -$10.88M -$11.87M -$14.58M -$9.76M -$364,000.00
Ending Cash Balance $46.15M $179.83M $41.01M $80.21M $80.21M
Net Change in Cash -$133.69M $138.82M -$39.21M -$3.22M $7.02M
Beginning Cash Balance $179.83M $41.01M $80.21M $83.43M $73.19M
Free Cash Flow $46.34M $52.57M $32.52M $135.41M $45.60M

Discussion

No comments yet — be the first to weigh in on AUPH.

Sign in to join the discussion.

Scroll to Top